PSCH Among Health Care ETFs
End-of-day Nov 17, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −2.7% | +6.1% | −0.9% | +26.5% | +31.9% | +59.1% | −12.3% | +153.0% | +588.0% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$48 of every $1,000 in PSCH is TG
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TGTXTG Therapeutics | Healthcare | 4.81% | $480.66 | 144K | $9.0M |
| 2 | PTGXProtagonist Therapeutics | Healthcare | 4.36% | $436.15 | 66K | $8.2M |
| 3 | ALKSAlkermes | Healthcare | 4.21% | $421.41 | 170K | $7.9M |
| 4 | TFXTeleflex | Healthcare | 3.59% | $359.43 | 43K | $6.8M |
| 5 | LGNDLigand Pharmaceuticals | Healthcare | 3.25% | $324.82 | 20K | $6.1M |
| 6 | SUPNSupernus | Healthcare | 3.23% | $323.06 | 211K | $6.1M |
| 7 | RDNTRadNet | Healthcare | 2.94% | $294.03 | 72K | $5.5M |
| 8 | MMSIMerit Medical Systems | Healthcare | 2.78% | $278.41 | 61K | $5.2M |
| 9 | CONConcentra Group Parent | Healthcare | 2.78% | $278.10 | 120K | $5.2M |
| 10 | PTCTPTC Therapeutics | Healthcare | 2.75% | $274.67 | 85K | $5.2M |
| 11 | ICUIICU Medical | Healthcare | 2.46% | $245.56 | 25K | $4.6M |
| 12 | LFSTLifeStance Health Group | Healthcare | 2.45% | $245.33 | 319K | $4.6M |
| 13 | ITGRInteger | Healthcare | 2.33% | $233.01 | 35K | $4.4M |
| 14 | LQDALiquidia | Healthcare | 2.26% | $226.12 | 75K | $4.3M |
| 15 | AMRXAmneal Pharmaceuticals | Healthcare | 2.12% | $211.60 | 188K | $4.0M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TGTX | TG Therapeutics | 4.81% |
| 2 | PTGX | Protagonist Therapeutics | 4.36% |
| 3 | ALKS | Alkermes | 4.21% |
| 4 | TFX | Teleflex | 3.59% |
| 5 | LGND | Ligand Pharmaceuticals | 3.25% |
| 6 | SUPN | Supernus | 3.23% |
| 7 | RDNT | RadNet | 2.94% |
| 8 | MMSI | Merit Medical Systems | 2.78% |
| 9 | CON | Concentra Group Parent | 2.78% |
| 10 | PTCT | PTC Therapeutics | 2.75% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Mar 23, 2026 | Mar 27, 2026 | $0.0003 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0026 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0020 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0142 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0180 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0659 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0361 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0045 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0017 |
| Dec 16, 2016 | Dec 30, 2016 | $0.0065 |
| Dec 24, 2014 | Dec 31, 2014 | $0.48 |
| Dec 19, 2014 | Dec 31, 2014 | $0.0092 |